Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hong-Wu Shen, Xi-Ling Jiang & Ai-Ming Yu. (2009) Development of a LC–MS/MS Method to Analyze 5-Methoxy-N,N-Dimethyltryptamine and Bufotenine: Application to Pharmacokinetic Study. Bioanalysis 1:1, pages 87-95.
Read now
Read now
Ai‐Ming Yu, Jeffrey R. Idle & Frank J. Gonzalez. (2004) Polymorphic Cytochrome P450 2D6: Humanized Mouse Model and Endogenous Substrates. Drug Metabolism Reviews 36:2, pages 243-277.
Read now
Read now
Articles from other publishers (47)
Gustavo Almeida e Silva, Vinícius Galvão Wakui, Lucília Kato & Cássia A. Marquezin. (2024) Spectroscopic behavior of bufotenine and bufotenine N-oxide: Solvent and pH effects and interaction with biomembrane models. Biochimica et Biophysica Acta (BBA) - Biomembranes 1866:4, pages 184304.
Crossref
Crossref
Yancheng Xie, Xue Feng, Jiaqi Tao, Qianhui Gao, Yue Li, Xinyi Liu, Mingyu Xia & Dong Wang. (2024) Cloning, characterization and specificity of a new aromatic-L-amino-acid decarboxylases from Bufo bufo gargarizans. International Journal of Biological Macromolecules 260, pages 129539.
Crossref
Crossref
Anastasiia Mikhailovna Bubnova & Alexey Vladimirovich Galchenko. (2024) Natural Aphrodisiacs: Traditional Use, Mechanism of Action, Clinical
Efficacy, and Safety. The Natural Products Journal 14:1.
Crossref
Crossref
Rubi Barman, Pranjit Kumar Bora, Jadumoni Saikia, Parthapratim Konwar, Aditya Sarkar, Phirose Kemprai, Siddhartha Proteem Saikia, Saikat Haldar, Adrian Slater & Dipanwita Banik. (2024) Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans. Phytochemistry 218, pages 113928.
Crossref
Crossref
Alexander M. Sherwood, Elise K. Burkhartzmeyer, Samuel E. Williamson, Michael H. Baumann & Grant C. Glatfelter. (2024) Psychedelic-like Activity of Norpsilocin Analogues. ACS Chemical Neuroscience 15:2, pages 315-327.
Crossref
Crossref
Wenwen Duan, Dongmei Cao, Sheng Wang & Jianjun Cheng. (2023)
Serotonin 2A Receptor (5-HT
2A
R) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
. Chemical Reviews 124:1, pages 124-163.
Crossref
Crossref
Francisco Madrid-Gambin, David Fabregat-Safont, Alex Gomez-Gomez, Eulàlia Olesti, Natasha L. Mason, Johannes G. Ramaekers & Oscar J. Pozo. (2023) Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans. Biomedicine & Pharmacotherapy 169, pages 115775.
Crossref
Crossref
Ali Asghar Hakami Zanjani, Teresa Quynh Tram Nguyen, Luise Jacobsen & Himanshu Khandelia. (2023) The molecular basis of the antidepressant action of the magic mushroom extract, psilocin. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1871:4, pages 140914.
Crossref
Crossref
Matthew Meyer & Jason Slot. (2023) The evolution and ecology of psilocybin in nature. Fungal Genetics and Biology 167, pages 103812.
Crossref
Crossref
Daniel G. Anstis, Jessica Liyu, Emma K. Davison & Jonathan Sperry. (2023) Alkaloids from the entheogenic plant Peganum harmala. Australian Journal of Chemistry 76:5, pages 264-278.
Crossref
Crossref
Erika Plazas & Nicoletta Faraone. (2023) Indole Alkaloids from Psychoactive Mushrooms: Chemical and Pharmacological Potential as Psychotherapeutic Agents. Biomedicines 11:2, pages 461.
Crossref
Crossref
Geir Bjørklund & Olha Storchylo. (2023) Bufo Rana in Homeopathy: Potentization, Toxicology, Clinical Consequences, and Therapeutic Use. ARS Medica Tomitana 29:1, pages 25-30.
Crossref
Crossref
Raúl López-Arnau, Jordi Camarasa, Marcel·lí Carbó, Núria Nadal-Gratacós, Pol Puigseslloses, María Espinosa-Velasco, Edurne Urquizu, Elena Escubedo & David Pubill. (2022) 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Frontiers in Psychiatry 13.
Crossref
Crossref
Claudius Lenz, Sebastian Dörner, Felix Trottmann, Christian Hertweck, Alexander Sherwood & Dirk Hoffmeister. (2022) Assessment of Bioactivity‐Modulating Pseudo‐Ring Formation in Psilocin and Related Tryptamines. ChemBioChem 23:13.
Crossref
Crossref
Johannes T. Reckweg, Malin V. Uthaug, Attila Szabo, Alan K. Davis, Rafael Lancelotta, Natasha L. Mason & Johannes G. Ramaekers. (2022) The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT). Journal of Neurochemistry 162:1, pages 128-146.
Crossref
Crossref
Xuanyi Wu, Maria Vega Cañamares, Ioanna Kakoulli & Santiago Sanchez-Cortes. (2022) Chemical Characterization and Molecular Dynamics Simulations of Bufotenine by Surface-Enhanced Raman Scattering (SERS) and Density Functional Theory (DFT). The Journal of Physical Chemistry Letters 13:25, pages 5831-5837.
Crossref
Crossref
Camila Mosca Barboza, Daniel Carvalho Pimenta, Hugo Vigerelli, Andréa de Cássia Rodrigues da Silva, Jaíne Gonçalves Garcia, Raphaela Mello Zamudio, Juliana Galera Castilho, Jarbas Alves Montanha, Paulo Michel Roehe & Helena Beatriz de Carvalho Ruthner Batista. (2021) In vitro effects of bufotenine against RNA and DNA viruses. Brazilian Journal of Microbiology 52:4, pages 2475-2482.
Crossref
Crossref
Xinmei Tan, Xueyan LiangJiaxi XiSitong GuoMingyu MengXiaoyu ChenYan Li. (2021) Clinical efficacy and safety of Huachansu injection combination with platinum-based chemotherapy for advanced non-small cell lung cancer. Medicine 100:36, pages e27161.
Crossref
Crossref
Yan Li, Jiaxi Xi, Sitong Guo, Henghai Su, Xiaoyu Chen & Xueyan Liang. (2021) Optimal Chinese herbal injections plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A systematic review and Bayesian network meta-analysis. Phytomedicine Plus 1:2, pages 100031.
Crossref
Crossref
Paul Cumming, Milan Scheidegger, Dario Dornbierer, Mikael Palner, Boris B. Quednow & Chantal Martin-Soelch. (2021) Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. Molecules 26:9, pages 2451.
Crossref
Crossref
Daniela Calina, Felix Carvalho & Anca Oana Docea. 2021. Toxicological Risk Assessment and Multi-System Health Impacts from Exposure. Toxicological Risk Assessment and Multi-System Health Impacts from Exposure
545
556
.
Claudius Lenz, Alexander Sherwood, Robert Kargbo & Dirk Hoffmeister. (2020)
Taking Different Roads:
l
‐Tryptophan as the Origin of
Psilocybe
Natural Products
. ChemPlusChem 86:1, pages 28-35.
Crossref
Crossref
Tehila Mishraki‐Berkowitz, Esti Kochelski, Pierce Kavanagh, John O'Brien, Clodagh Dunne, Brian Talbot, Patricia Ennis & Udi (Ehud) Wolf. (2020) The Psilocin (4‐hydroxy‐N,N‐dimethyltryptamine) and Bufotenine (5‐hydroxy‐N,N‐dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified. Journal of Forensic Sciences 65:5, pages 1450-1457.
Crossref
Crossref
Francesca Protti-Sánchez, Luis Quirós-Guerrero, Víctor Vásquez, Beatriz Willink, Mariano Pacheco, Edwin León, Heike Pröhl & Federico Bolaños. (2019) Toxicity and Alkaloid Profiling of the Skin of the Golfo Dulcean Poison Frog Phyllobates vittatus (Dendrobatidae). Journal of Chemical Ecology 45:11-12, pages 914-925.
Crossref
Crossref
Siu Wa Tang & Wayne H Tang. (2019) Opportunities in Novel Psychotropic Drug Design from Natural Compounds. International Journal of Neuropsychopharmacology 22:9, pages 601-607.
Crossref
Crossref
Hugo Vigerelli, Juliana Mozer Sciani, Maria Andrea Camarano Eula, Luciana Almeida Sato, Marta M. Antoniazzi, Carlos Jared & Daniel C. Pimenta. (2018) Biological Effects and Biodistribution of Bufotenine on Mice. BioMed Research International 2018, pages 1-10.
Crossref
Crossref
Laura Orsolini, Michela Ciccarese, Duccio Papanti, Domenico De Berardis, Amira Guirguis, John M. Corkery & Fabrizio Schifano. (2018) Psychedelic Fauna for Psychonaut Hunters: A Mini-Review. Frontiers in Psychiatry 9.
Crossref
Crossref
Joseph P. Barsuglia, Martin Polanco, Robert Palmer, Benjamin J. Malcolm, Benjamin Kelmendi & Tanya Calvey. 2018. Psychedelic Neuroscience. Psychedelic Neuroscience
121
158
.
E. V. Kryukova, D. S. Lebedev, I. A. Ivanov, D. A. Ivanov, V. G. Starkov, V. I. Tsetlin & Yu. N. Utkin. (2017) N-methyl serotonin analogues from the Bufo bufo toad venom interact efficiently with the α7 nicotinic acetylcholine receptors. Doklady Biochemistry and Biophysics 472:1, pages 52-55.
Crossref
Crossref
Elisa Correa Fornari Baldo, Fernando Antonio Pino Anjolette, Eliane Candiani Arantes & Mateus Amaral Baldo. 2017. Toxins and Drug Discovery. Toxins and Drug Discovery
373
399
.
Curtis P. Snook. 2017. Critical Care Toxicology. Critical Care Toxicology
1587
1607
.
Philippe Coulon & Ali Gorji. (2016) Tightrope or Slackline? The Neuroscience of Psychoactive Substances. Trends in Pharmacological Sciences 37:7, pages 511-521.
Crossref
Crossref
Curtis P. Snook. 2016. Critical Care Toxicology. Critical Care Toxicology
1
22
.
Bingduo Zhou, Fengying Wu, Lin Yuan, Zhulei Miao & Shengliang Zhu. (2015) Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy. Evidence-Based Complementary and Alternative Medicine 2015, pages 1-11.
Crossref
Crossref
Piotr Paweł Wieczorek, Danuta Witkowska, Izabela Jasicka-Misiak, Anna Poliwoda, Milena Oterman & Katarzyna Zielińska. 2015.
133
168
.
Elisa Correa Fornari Baldo, Fernando Antonio Pino Anjolette, Eliane Candiani Arantes & Mateus Amaral Baldo. 2015. Toxins and Drug Discovery. Toxins and Drug Discovery
1
22
.
Xi-Ling Jiang, Hong-Wu Shen, Donald E. Mager & Ai-Ming Yu. (2013)
Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-
N,N
-Dimethyltryptamine, and the Impact of CYP2D6 Status
. Drug Metabolism and Disposition 41:5, pages 975-986.
Crossref
Crossref
Alisa G Woods, Armand G Ngounou Wetie, Izabela Sokolowska, Stefanie Russell, Jeanne P Ryan, Tanja Michel, Johannes Thome & Costel C Darie. (2013) Mass spectrometry as a tool for studying autism spectrum disorder. Journal of Molecular Psychiatry 1:1, pages 6.
Crossref
Crossref
Daniel I. Brierley & Colin Davidson. (2012) Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 263-272.
Crossref
Crossref
Cullen L. Schmid & Laura M. Bohn. (2010)
Serotonin, But Not
N
-Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex
In Vivo
. The Journal of Neuroscience 30:40, pages 13513-13524.
Crossref
Crossref
Hong-Wu Shen, Chao Wu, Xi-Ling Jiang & Ai-Ming Yu. (2010) Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics. Biochemical Pharmacology 80:1, pages 122-128.
Crossref
Crossref
Ashwin A. Patkar, Steve Rozen, Paolo Mannelli, Wayne Matson, Chi-Un Pae, K. Ranga Krishnan & Rima Kaddurah-Daouk. (2009) Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology 206:3, pages 479-489.
Crossref
Crossref
Ai-Ming Yu. (2008) Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions. The AAPS Journal 10:2.
Crossref
Crossref
John C.M. Brust. 2007. Aspects neurologiques de l'addiction. Aspects neurologiques de l'addiction
315
334
.
John C.M. Brust. 2004. Neurological Aspects of Substance Abuse. Neurological Aspects of Substance Abuse
259
274
.
Jesse A. May, Marsha A. McLaughlin, Najam A. Sharif, Mark R. Hellberg & Thomas R. Dean. (2003)
Evaluation of the Ocular Hypotensive Response of Serotonin 5-HT
1A
and 5-HT
2
Receptor Ligands in Conscious Ocular Hypertensive Cynomolgus Monkeys
. Journal of Pharmacology and Experimental Therapeutics 306:1, pages 301-309.
Crossref
Crossref
Ai-Ming Yu, Jeffrey Idle, Tomas Herraiz, Adrian Kupfer & Frank Gonzalez. (2003) Pharmacogenetics 13:6, pages 307-319.
Crossref
Crossref